David Krempa
Corporate Officer/Principal en ETON PHARMACEUTICALS, INC. .
Fortuna: 64 899 $ al 30/04/2024
Perfil
David C.
Krempa is currently the Chief Business Officer at Eton Pharmaceuticals, Inc. He previously worked at Akorn, Inc. in Business Development-Sagent Pharmaceuticals.
Additionally, he worked as an Equity Analyst at Morningstar, Inc. (Research) from 2014 to 2015.
Mr. Krempa completed his undergraduate degree at DePaul University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/04/2024 | 20 801 ( 0.08% ) | 64 899 $ | 30/04/2024 |
Cargos activos de David Krempa
| Empresas | Cargo | Inicio |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
Antiguos cargos conocidos de David Krempa.
| Empresas | Cargo | Fin |
|---|---|---|
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 01/03/2015 |
| AKORN, INC. | Corporate Officer/Principal | - |
Formación de David Krempa.
| DePaul University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
- Bolsa de valores
- Insiders
- David Krempa